Report cover image

Australia and New Zealand Diabetes Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

Publisher Mordor Intelligence Inc
Published Jan 17, 2022
Length 78 Pages
SKU # MOI16951035

Description

Australia and New Zealand Diabetes Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

Key Highlights
  • Australia and New Zealand Diabetes Devices Market, expected to register a CAGR of about 7.7% during the forecast period (2019-2024).
  • A holistic study of the market studied has been carried out by incorporating various factors, extending from country-specific demographic conditions and business cycles to market-specific microeconomic influences, which were needed to analyze future trends.
  • The research uncovers many paradigm shifts in the market studied, in terms of regional competitive advantage and dynamics, primarily to services.
Key Market TrendsBetween the two countries, Australia dominated the market with the highest market share.
  • The market studied accounted for USD 0.29 billion in 2018 and is expected to reach USD 0.46 billion by 2024, witnessing a CAGR of 7.7% for 2019-2024.
  • Between Australia and New Zealand, Australia dominated the market with the highest market share 86.2%.
  • Australia having the highest market share because in Australia, Around 1.31 million patients were diagnosed with diabetes in 2018, and more than 100,000 people developed diabetes during the same year.
  • The diabetes population in Australia is expected to reach 1.55 million by 2024. Diabetes has become the biggest challenge in the country.
Monitoring devices holds the highest market with USD 0.16 billion.
  • In Australia and New Zealand Diabetes Devices Market, Monitoring devices holds the highest market with USD 0.16 billion.
  • Innovations in the Monitoring devices market help to increase the market of Australia and New Zealand Diabetes Monitoring devices market, like continuous glucose monitors (CGM), help the patients to measure the blood glucose levels with zero finger pricks.
  • In New Zealand, Pharmac (Pharmaceuticals Management Agency) is funding most health care consumables. And started funding on care sense pro blood glucose test strips from August 2018 until 2022. In New Zealand, about 12,000 patients are using test strips frequently.
Competitive Landscape

There have been constant innovations driven by manufacturers to compete and struggle in the market. The major players, such as Roche, resort to inorganic market strategies, such as mergers and acquisitions, to establish market dominance, while also adhering to organic growth strategies, which is evident from the R&D spending of these companies. Examples of a few strategic outcomes include:

  • Roche completed the acquisition of Flatiron Health in 2018
  • In 2018, The Ascensia diabetes company’s product- Contour next blood glucose monitoring system complies with the study protocol defined in recently published independent accuracy assessment by the diabetes technology society
Additional Benefits:
  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support
Please note: This publisher does offer titles that are created upon receipt of order. If you are purchasing a PDF Email Delivery option above, the report will take approximately 2 business days to prepare and deliver.

Table of Contents

78 Pages
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Drivers
4.3 Restraints
4.4 Porter's Five Forces Analysis
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Consumers
4.4.3 Threat of New Entrants
4.4.4 Threat of Substitute Products and Services
4.4.5 Intensity of Competitive Rivalry
5 Market Segmentation
5.1 By product
5.1.1 By Monitoring Devices, Value & Volume (2012-2024)
5.1.1.1 Self-Monitoring Blood Glucose
5.1.1.1.1 Glucometer Devices
5.1.1.1.2 Blood Glucose Test Strips
5.1.1.1.3 Lancets
5.1.1.2 Continuous Glucose Monitoring
5.1.1.2.1 Sensors
5.1.1.2.2 Receivers
5.1.2 By Management Devices, Value & Volume (2012-2024)
5.1.2.1 Insulin Pump
5.1.2.1.1 Insulin Pump Device
5.1.2.1.2 Insulin Pump Reservoir
5.1.2.1.3 Infusion Set
5.1.2.2 Syringes
5.1.2.3 Cartridges
5.1.2.4 Disposable Pens
5.1.2.5 Jet Injectors
5.2 Geography
5.2.1 Australia
5.2.1.1 By Monitoring Devices (Glucometer Devices, Blood Glucose Test Strips, Lancets, Sensors, Receivers)
5.2.1.2 By Management Devices (Insulin Pump Device, Insulin Pump Reservior, Infusion Set, Syringes, Cartridges, Disposable pens, Jet Injectors)
5.2.2 New Zealand
5.2.2.1 By Monitoring Devices (Glucometer Devices, Blood Glucose Test Strips, Lancets, Sensors, Receivers)
5.2.2.2 By Management Devices (Insulin Pump Device, Insulin Pump Reservior, Infusion Set, Syringes, Cartridges, Disposable pens, Jet Injectors)
6 COMPETITIVE LANDSCAPE
6.1 Abbott
6.1.1 Overview
6.1.2 Products and Strategies
6.1.3 Recent Development
6.2 Roche
6.2.1 Overview
6.2.2 Products and Strategies
6.2.3 Recent Development
6.3 Johnson & Johnson
6.3.1 Overview
6.3.2 Products and Strategies
6.3.3 Recent Development
6.4 Dexcom
6.4.1 Overview
6.4.2 Products and Strategies
6.4.3 Recent Development
6.5 Becton and Dickenson
6.5.1 Overview
6.5.2 Products and Strategies
6.5.3 Recent Development
6.6 Medtronic
6.6.1 Overview
6.6.2 Products and Strategies
6.6.3 Recent Development
6.7 Insulet
6.7.1 Overview
6.7.2 Products and Strategies
6.7.3 Recent Development
6.8 Ypsomed
6.8.1 Overview
6.8.2 Products and Strategies
6.8.3 Recent Development
6.9 Novo Nordisk
6.9.1 Overview
6.9.2 Products and Strategies
6.9.3 Recent Development
6.10 Sanofi
6.10.1 Overview
6.10.2 Products and Strategies
6.10.3 Recent Development
6.11 Eli Lilly
6.11.1 Overview
6.11.2 Products and Strategies
6.11.3 Recent Development
7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us